Johnson & Johnson Price to Sales Ratio 2006-2018 | JNJ

Historical PS ratio values for Johnson & Johnson (JNJ) over the last 10 years. The current P/S ratio for Johnson & Johnson as of February 15, 2019 is .
Johnson & Johnson P/S Ratio Historical Data
Date Stock Price TTM Sales per Share Price to Sales Ratio
2019-02-15 136.38 4.56
2018-12-31 129.05 $29.93 4.31
2018-09-30 138.17 $29.79 4.64
2018-06-30 121.34 $29.51 4.11
2018-03-31 127.21 $28.73 4.43
2017-12-31 137.82 $27.86 4.95
2017-09-30 127.46 $26.99 4.72
2017-06-30 128.88 $26.21 4.92
2017-03-31 120.54 $25.95 4.64
2016-12-31 110.78 $25.74 4.30
2016-09-30 112.81 $25.58 4.41
2016-06-30 115.07 $25.27 4.55
2016-03-31 101.91 $24.98 4.08
2015-12-31 96.06 $24.90 3.86
2015-09-30 86.66 $24.94 3.48
2015-06-30 89.78 $25.29 3.55
2015-03-31 91.99 $25.75 3.57
2014-12-31 94.96 $25.91 3.67
2014-09-30 96.17 $25.91 3.71
2014-06-30 93.76 $25.56 3.67
2014-03-31 87.43 $24.96 3.50
2013-12-31 80.93 $24.78 3.27
2013-09-30 76.08 $24.65 3.09
2013-06-30 74.79 $24.60 3.04
2013-03-31 70.48 $24.30 2.90
2012-12-31 60.12 $24.00 2.51
2012-09-30 58.59 $23.61 2.48
2012-06-30 56.93 $23.32 2.44
2012-03-31 55.04 $23.40 2.35
2011-12-31 54.25 $23.42 2.32
2011-09-30 52.20 $23.17 2.25
2011-06-30 54.04 $22.79 2.37
2011-03-31 47.72 $22.30 2.14
2010-12-31 49.37 $22.06 2.24
2010-09-30 49.03 $22.38 2.19
2010-06-30 46.30 $22.40 2.07
2010-03-31 50.65 $22.40 2.26
2009-12-31 49.65 $22.20 2.24
2009-09-30 46.57 $21.62 2.15
2009-06-30 43.10 $21.84 1.97
2009-03-31 39.56 $22.15 1.79
2008-12-31 44.62 $22.41 1.99
2008-09-30 51.27 $22.54 2.27
2008-06-30 47.31 $22.05 2.15
2008-03-31 47.36 $21.45 2.21
2007-12-31 48.38 $20.94 2.31
2007-09-30 47.36 $20.08 2.36
2007-06-30 44.12 $19.45 2.27
2007-03-31 42.87 $18.76 2.28
2006-12-31 46.70 $17.96 2.60
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $365.894B $81.581B
Johnson & Johnson is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. Its Consumer segment offers products for use in the baby care, skin care, oral care, wound care, and women's health fields, nutritional and over-the-counter pharmaceutical products. The company's Pharmaceutical segment provides various products in the areas of anti-infective, antipsychotic, contraceptive, dermatology, gastrointestinal, hematology, immunology, neurology, oncology, pain management, thrombosis, vaccines, and infectious diseases. Its Medical Devices and Diagnostics segment offers electrophysiology and circulatory disease management products; orthopaedic joint reconstruction, spinal care, neurological, and sports medicine products; surgical care, aesthetics, and women's health products. Johnson & Johnson is based in New Brunswick, New Jersey.
Stock Name Country Market Cap PE Ratio
Pfizer (PFE) United States $252.402B 14.13
Merck (MRK) United States $215.183B 18.39
Novartis AG (NVS) Switzerland $207.623B 17.66
Eli Lilly (LLY) United States $129.746B 22.03
Novo Nordisk (NVO) Denmark $123.032B 19.90
AbbVie (ABBV) United States $121.616B 10.22
Sanofi (SNY) France $106.719B 13.17
AstraZeneca (AZN) United Kingdom $103.646B 11.83
GlaxoSmithKline (GSK) United Kingdom $102.300B 13.43
Bristol-Myers Squibb (BMY) United States $84.336B 12.98